Novo Nordisk A/S (NVO) — closed signal from July 11, 2025
Partial Published before the outcome was known, scored automatically when the window closed on October 9, 2025.
Predicted vs. what happened
What happened
Reached 4% of the predicted growth at its peak, without hitting the target.
The thesis — published July 11, 2025
The company still cannot make enough of its popular diabetes drug to meet demand, so it can keep prices strong. Even though the stock has sat near 70 dollars for about a month and a half, trading activity is lively and investor mood is very upbeat. A ruling expected in Q3 to let the drug be used by children, plus the end of a small legal dispute, could push the price past 72.50 and toward the low 90s within three months, backed by its large cash pile.
Primary drivers
- More orders than supply for main drug may lift yearly sales about 30 percent
- Recent average price is rising and trading is steady, showing steady buying
- Child-use approval decision in Q3 could give the share a near-term spark
- Cancelling the Hims agreement on 11 July removes worries and cheers investors
How it played out
NVO: target was not reached
Lyra published NVO at 70.22 on 2025-07-11 with expected growth of 26 percent. The target was 87.49. The thesis pointed to more orders than supply for the main drug, yearly sales growth of about 30 percent, steady buying, a possible Q3 child-use approval decision, the Hims agreement cancellation on 11 July, and a large cash pile.
Inside the window, NVO peaked at 71 on 2025-07-25, a 1.1 percent gain. It never reached 87.49, and it stayed below the 72.50 level the thesis said could open the path toward the low 90s. The window ended at 58.68. The thesis missed.
What happened during the window
On 2025-07-29, Novo Nordisk cut its 2025 sales growth outlook and named Maziar Mike Doustdar as its next CEO, effective 2025-08-07. On 2025-09-10, the company announced a restructuring with 9,000 job cuts and lowered its 2025 profit forecast.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.